All Companies

Company Description Status Initial Datesort icon
<a href="/venture-capital/all-companies/eleven-biotherapeutics-inc">Eleven Biotherapeutics, Inc.</a> Discovering and developing protein therapeutics to treat diseases of the eye. Public 2008 View Profile
<a href="/venture-capital/all-companies/visterra-inc">Visterra, Inc.</a> Discovering and developing innovative products that will transform the prevention and treatment of infectious diseases. Private 2008 View Profile
<a href="/venture-capital/all-companies/agios-pharmaceuticals-inc">Agios Pharmaceuticals, Inc.</a> Discovering and developing novel drugs to treat cancer and inborn errors of metabolism. Public 2007 View Profile
<a href="/venture-capital/all-companies/joule-unlimited-inc">Joule Unlimited, Inc.</a> Pioneering a CO2-to-fuel production platform, effectively reversing combustion through the use of solar energy. Private 2007 View Profile
<a href="/venture-capital/all-companies/seventh-sense-biosystems-inc">Seventh Sense Biosystems, Inc.</a> Developing an array of products based on the company's proprietary TAP™ (Touch Activated Phlebotomy) painless blood collection platform. Private 2007 View Profile
<a href="/venture-capital/all-companies/bind-therapeutics-inc">BIND Therapeutics, Inc.</a> Developing Accurins, its novel targeted therapeutics. Public 2007 View Profile
<a href="/venture-capital/all-companies/novomer-inc">Novomer, Inc.</a> Commercializing a family of low-cost, high-performance, sustainable polymers and other chemicals. Private 2007 View Profile
<a href="/venture-capital/all-companies/quanterix-corporation">Quanterix Corporation</a> Developing ground-breaking tools in high definition diagnostics. Private 2007 View Profile
<a href="/venture-capital/all-companies/hypnion-inc">Hypnion, Inc.</a> Platform technology enabling novel therapies for treatment of sleep disorders Acquired 2007 View Profile
<a href="/venture-capital/all-companies/concert-pharmaceuticals-inc">Concert Pharmaceuticals, Inc.</a> Applying the company’s DCE Platform® (deuterated chemical entity platform) to create novel and differentiated small molecule drugs. Public 2006 View Profile
<a href="/venture-capital/all-companies/t2-biosystems-inc">T2 Biosystems, Inc.</a> Using T2MR to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare. Private 2006 View Profile
<a href="/venture-capital/all-companies/alvine-pharmaceuticals-inc">Alvine Pharmaceuticals, Inc.</a> Developing biologics to target autoimmune/inflammatory diseases. Private 2006 View Profile
<a href="/venture-capital/all-companies/mascoma-corporation">Mascoma Corporation</a> Leading technology for the conversion of biomass to fuels and chemicals. Private 2006 View Profile
<a href="/venture-capital/all-companies/tetraphase-pharmaceuticals-inc">Tetraphase Pharmaceuticals, Inc.</a> Creating novel antibiotics for serious and life-threatening multidrug-resistant (MDR) bacterial infections. Public 2006 View Profile
<a href="/venture-capital/all-companies/ls9">LS9</a> Leading renewable chemical technology developer. Acquired 2005 View Profile
<a href="/venture-capital/all-companies/visen-medical-inc">VisEn Medical, Inc.</a> Pioneering a new era of in vivo imaging. Acquired 2005 View Profile
<a href="/venture-capital/all-companies/resolvyx-pharmaceuticals-inc">Resolvyx Pharmaceuticals, Inc.</a> Developing resolvins, a novel class of therapies to treat inflammatory diseases and their complications. Private 2005 View Profile
<a href="/venture-capital/all-companies/interactive-supercomputing-corporation">Interactive Supercomputing Corporation</a> Software to enable applications transparent use of cluster supercomputers Acquired 2005 View Profile
<a href="/venture-capital/all-companies/intio">INTIO</a> Developing a software platform to support the emerging interventional oncology market. Private 2005 View Profile
<a href="/venture-capital/all-companies/acceleron-pharma-inc">Acceleron Pharma, Inc.</a> Discovering, developing and commercializing novel protein therapeutics for cancer and rare diseases. Public 2004 View Profile